HOB Biotech (China) Today
| 688656 Stock | 110.00 2.85 2.53% |
Performance29 of 100
| Odds Of DistressLess than 2
|
HOB Biotech is trading at 110.00 as of the 11th of December 2024, a 2.53 percent decrease since the beginning of the trading day. The stock's open price was 112.85. HOB Biotech has a very small chance of experiencing financial distress in the next few years and had a strong performance during the last 90 days. The performance scores are derived for the period starting the 19th of August 2023 and ending today, the 11th of December 2024. Click here to learn more.
Business Domain Health Care Equipment & Services | Category Healthcare | Classification Health Care |
HOB Biotech is entity of China. It is traded as Stock on SHG exchange. The company has 63.06 M outstanding shares. More on HOB Biotech Group
Moving together with HOB Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
HOB Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. HOB Biotech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding HOB Biotech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Chairman GM | John Li | ||||
| Thematic Idea | IT (View all Themes) | ||||
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, IT, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare, Computing (View all Sectors) | ||||
HOB Biotech's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to HOB Biotech's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsHOB Biotech can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand HOB Biotech's financial leverage. It provides some insight into what part of HOB Biotech's total assets is financed by creditors.
| |||||
HOB Biotech Group (688656) is traded on Shanghai Stock Exchange in China and employs 550 people. HOB Biotech is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 6.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate HOB Biotech's market, we take the total number of its shares issued and multiply it by HOB Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. HOB Biotech Group operates under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 63.06 M outstanding shares.
HOB Biotech generates positive cash flow from operations, but has no cash available
Check HOB Biotech Probability Of Bankruptcy
Ownership AllocationHOB Biotech Group secures a total of 63.06 Million outstanding shares. HOB Biotech owns majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 77.69 % of HOB Biotech Group outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check HOB Ownership Details
HOB Biotech Group Risk Profiles
Although HOB Biotech's alpha and beta are two of the key measurements used to evaluate HOB Biotech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 5.69 | |||
| Semi Deviation | 3.57 | |||
| Standard Deviation | 7.8 | |||
| Variance | 60.85 |
HOB Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in HOB Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
HOB Biotech Corporate Management
Elected by the shareholders, the HOB Biotech's board of directors comprises two types of representatives: HOB Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of HOB. The board's role is to monitor HOB Biotech's management team and ensure that shareholders' interests are well served. HOB Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, HOB Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiaohua Huang | Deputy Manager | Profile | |
| Ruoliang Sun | Deputy Manager | Profile | |
| Shuyan Han | Chief Officer | Profile | |
| Aixiang Xie | Secretary | Profile | |
| Yi Li | Financial Manager | Profile |
Other Information on Investing in HOB Stock
HOB Biotech financial ratios help investors to determine whether HOB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HOB with respect to the benefits of owning HOB Biotech security.